Teva Pharmaceuticals Industries Ltd. said late Monday it is selling its Paragard IUD product to Cooper Cos. for $1.1 billion cash. Paraguard had sales of about $168 million for the 12 months ending June 30. The deal includes Teva’s plant in Buffalo, N.Y., which makes the Paragard. The deal is expected to close by the end of the year. Teva said it will continue to divest the remaining assets in its women’s health business, and in its oncology and pain relief businesses in Europe. Cooper said it expects the deal to add 70 cents to 75 cents a share to earnings in the first year. U.S.-traded Teva shares rose 1.1% to $18.72 after hours, while Cooper shares gained 0.2% to $254. On Monday, Teva shares had their biggest one-day gain since 1984 following the naming of a new chief executive.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News